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THE SPILL OUT OF SARS-CoV-2
An outbreak of viral pneumonia was reported in Wuhan, China, at the end of December 2019,
and subsequent sample analyses discovered the involvement of a new strain of coronavirus
(SARS-CoV-2), which belongs to the same family of single-stranded enveloped RNA viruses that
caused the emergences of SARS-CoV in 2003 and MERS-CoV in 2012. Symptoms of COVID-19
(SARS-CoV-2 syndrome) may occur within 2–14 days after exposure and can lead to difficulties
in cilium beating of airway cells and to alveolar damage (1). Infected patients experience mild to
severe manifestations, such as fever, dry cough, dyspnoea, abdominal pain, and diarrhea. Most
cases resolve rapidly, but the infection can still be fatal in about 3% of cases (2). Much like MERS
or the coronavirus that infects pigs, the enteric affections can be prominent (3, 4), possibly leading
to the loss of absorptive potential. Just a few weeks after its discovery, the COVID-19 has been
considered a serious worldwide threat. At the time of writing, Italy is the worst-hit country with
97,689 confirmed cases and 10,781 total deaths (WHO COVID-19 Situation report 70, 30 March
2020). Preliminary data suggest that male older adults and subjects with immune dysfunctions
might be more susceptible to the worse viral disease, but there is a need to further investigate
the virulence factors. One of the factors most discussed is the malnutritional status of the host,
but most of the beliefs are anecdotal. On the other hand, strong evidence supports the notion
that any infection outcome is highly dependent on the nutritional status of the host since viruses
subject the host’s body to a considerable energetic effort to sustain costly defenses. If a previous
malnutritional status exists, or if no nutritional care is provided, the host easily encounters the
emptying of body reservoirs with increased harm caused by the virus. A possible link between the
nutritional status of the host, the virulence of SARS-CoV-2, and the clinical outcome of COVID-19
needs to be discussed.
THE HOST ABILITIES AGAINST INFECTIONS
A distinction should be made between the susceptibility to developing a symptomatic infection,
from now on referred to as “first-line host ability,” and the fighting potential, referred to as “second-
line host ability.” From the perspective of infectious diseases, the first-line host ability is expressed
by its immunocompetence, which is in turn uttered by the nutrient intake-requirement balance.
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Amalnutritional status refers to any balance deviation, including
the general excess, insufficiency, or single-nutrient deficits. The
second-line host ability is expressed by the endurance or ability
to persist in fighting the infection. For SARS-CoV-2, it can
be assumed that the healthier is the nutritional status of the
host, the higher are the first-line host abilities, the lower is
the susceptibility to COVID-19, the lower is the virulence of
SARS-CoV-2, and, thus, the longer the host will endure in the
fight. This transitive relation is not necessarily assumable for
all pathogens. Concerning parasitic infections, well-nourished
subjects may offer a wealthier environment to developing
parasites than malnourished individuals (5), but they can also
afford investments to endure in the fight, still having the upper
hand on the infection outcome. Whatever the nature of the
susceptibility to viral infections, second-line host abilities are
based not only on the ability to support an adequate immune
response but rely also on the body’s ability to support an
extensive controlled catabolic cytokine flow. Once infected, the
nutritional reservoirs have been shown to influence outcomes
in many diseases, comprising the immunodeficiency virus, the
influenza virus, or pneumonia (6, 7). The within-host reservoirs
depend on the external environment (8); the highest resources
should exist in hosts living in the wealthiest environments.
Regrettably, even the wealthiest countries present high rates of
deficiency syndromes.
THE HOST REACTIONS AGAINST
SARS-CoV-2
Both first- and second-line host abilities are necessary to heal
from SARS-CoV-2 infection. Once the virus gets inside the
airways through respiratory droplets, it infects local cells and
evokes the host immune response. Mild symptoms of COVID-
19 may be triggered by a local inflammation limited to the
lungs that should resolve quickly. Asymptomatic individuals have
been reported to have no high fever (no increased expenditure)
and no SARS-CoV-2-derived gastrointestinal symptoms that
could have affected dietary intakes (9). The immunocompetent
host response in non-severe cases recruits immune cell
populations, such as CD4/CD8T cells and antibody-secreting
cells together with specific immunoglobulin (Ig)M and IgG
SARS-CoV-2-binding antibodies (10). Basic treatments comprise
intravenous antibiotics, antiviral therapy, antifungalmedications,
systemic glucocorticoids, and interferon. In cases with comorbid
conditions, such as cardiovascular diseases and diabetes (11),
there may be a basal immune dysfunction since the elderly
and sick are often malnourished. If the immunoincompetence
fails to control the SARS-CoV-2 or the virus replicates faster
than expected, a severe inflammatory condition then arises and
spreads to other organs together with the virus. Worsened
patients show lymphopenia, cytokine storm (12), and multiple
organ failure (13). These biochemical signs together with the
decrease in CD4T cells are a common feature in patients with
COVID-19 and might be a critical virulence factor (14). The
intestines may be particularly suitable for viral proliferation,
as gut tropism in not unusual for coronaviruses. The host’s
ability to endure may depend on energy-nutrient intakes,
which may be hampered by gastrointestinal symptoms and the
hypermetabolism. Higher rates of nausea, vomiting, and diarrhea
were observed in severe COVID-19 patients, which appear to be
more likely to have anorexia (15). The prevalence of malnutrition
(probably hyponutrition) was 3% among the deceased vs. 0%
among survivors (16). Healthy body reservoirs, early adaptive
immune potential, and nutritional care may indeed be associated
with better outcomes from COVID-19.
THE DISABILITIES OF MALNOURISHED
INDIVIDUALS DURING INFECTIONS
“Malnutrition is the primary cause of immunodeficiency
worldwide” (17) and affects both the innate and adaptive immune
responses (18) that should inhibit viral proliferation. Chronic
diseases, which have been recognized as virulence factors for
severe COVID-19, are often comorbid with protein-energy
malnutrition (also known as disease-related malnutrition), which
is known to impair immune cell activation (19, 20), thus allowing
longer viral persistence and increased trafficking of inflammatory
cells to lungs (21). The basal immunoincompetence (22)
can be further aggravated upon infection (23). Insufficient
protein intakes may lead to nutrition-related sarcopenia. The
concomitant excess of adiposity has been defined as “sarcopenic
obesity” and carries issues of both conditions. Increased body
fat sustains a systemic low-grade inflammation, primarily
because of the leptin-induced CD4 T-cell function that increases
autoimmunity (24). Basal T cells are more prone to exhaustion
in obese subjects (25) who may therefore be more exposed to
SARS-CoV-2 proliferation, as occurs with the herpes simplex
virus (26). In fact, exhausted T cells exhibit poor effector function,
proliferation, and cytotoxicity (27). During the 2009 pandemic
caused by the influenza A (H1N1)pdm09 virus, obesity was found
to be a virulence factor for a more severe outcome (28) much
like for respiratory infections (29). Micronutrient deficiencies
are also a rising issue among malnourished subjects. Vitamins
have a role in the proper functioning of both the innate and
adaptive immune responses, with vitamin D and A being the
main actors (30). For instance, vitamin D is important for the
proper functioning of antibody-secreting cells (31) and vitamin
A sustains T-cell proliferation (32). The immune dysfunction
in hyponutritional statuses can be linked to these deficiencies
alike the excess of feeding, which is often associated with a
monotonous diet and therefore low in sources of vitamins. A
plethora of other micronutrients is known to have a role in the
immunocompetence of the host against infections, including B
vitamins, vitamin C, vitamin E, iron, selenium, and zinc (33),
with malnourished individuals often suffering from the most.
Malnutritional statuses carry less endurance to survive from
severe COVID-19. Hypermetabolism and excessive nitrogen loss
are factors known to be associated with infective states, and
malnourished individuals are therefore disadvantaged because
of the lesser body reserves. For instance, infected mice fed with
lesser proteins, iron, and zinc than the optimal requirements were
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found to encounter a significant decrease in both weight and
effector CD4T cells vs. normal nourished animals (34).
NUTRITIONAL CARE IN COVID-19
If the patient had a good nutritional status before infection,
then body reserves and basal dietary intake would assure the
coverage of costly immune defenses in mild conditions. If a
malnutritional status was present, which is very common among
older adults, then increased requirements should be provided
since the infection is expected to be protracted (35). Mild
cases might experience a loss of appetite often accompanied
by insomnia, nausea, vomiting, and reduced oral intakes,
thus further compromising the basal poor nutritional. Even
subacute malnourished patients are more prone to adverse events
than healthy counterparts upon hospital admission (36). Once
mechanical ventilation, extracorporeal membrane oxygenation,
and renal-replacement therapy have been introduced, parenteral
nutrition is the sole option. Severe cases with fever have
increased energy expenditure and requirements for each degree
of temperature increase. The usage of muscle-derived amino
acids for immune protein synthesis increases whole-body glucose
and nitrogen excretion, with a significant energy cost of immune
upregulation (37). Unfortunately, the increased adiposity of
obese individuals is not effectively used during infections (38),
and the breakdown of the already poor muscle mass can have
severe consequences. Similar metabolic consequences are seen
in older trauma patients, with the malnourished subjects being
the most at risk of adverse clinical outcomes (39). If energy
and protein requirements are met, then the emptying of body
FIGURE 1 | The SARS-CoV-2 virulence and the malnutritional status of the human host: immune-based dysfunctions in hypo- and hypernutrition. The severe acute
respiratory syndrome coronavirus that was discovered in Hubei province, China, at the end of December 2019 (SARS-CoV-2) is a single-strand positive-sense RNA
virus with the encoding potential of four structural proteins: the spike (S), the envelope (E), the membrane (M), and the nucleocapsid (N). It spreads through respiratory
droplets of infected patients that can deposit on body parts and fomites. The basal immune dysfunction that exists in protein-energy malnutrition and sarcopenic
obesity can make individuals more susceptible to SARS-CoV-2 contraction and affections. Other than the collapse of alveoli and respiratory failure, the coronavirus
replication leads to systemic consequences in the brain, liver, kidneys, and gut. Once affected, malnourished individuals will have fewer body reservoirs and immune
potential to fight for recovery.
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reservoirs may be avoided, and the immune response may
be sustained. Once full-blown, COVID-19 patients should be
supported with proper nutrition aimed at delivering adequate
proteins (1.5–2.0 g/kg/day likely needed), energy (105–160
kj/kg/day or 25–40 kcal/kg/day), vitamins, and trace elements.
Nutrition should be titrated up to meet higher requirements
because the delivery of the highest energy during the initial phase
may be counterproductive. Guidelines for polymorbid patients
should be followed (40–42). Partial isocaloric replacement of
carbohydrates with lipids may be considered to reduce the
production of CO2 by 30% per caloric unit (43).
CONCLUSION
In the current pandemic panorama of SARS-CoV-2, the link
between nutrition and virulence takes a predictable turn. On
one hand, many opportunists boast dietary plans against SARS-
CoV-2, and, on the other hand, there is the sellout of dietary
supplements that boost the immune system. In Italy, many
instances of fake news have circulated on social networks,
and many pharmacies have exposed signs that state: “Masks
sold-out but vitamin C available.” In these times of fear and
confusion, speculations should be disciplined. Nonetheless, a
greater understanding of the link between nutrition and SARS-
CoV-2 is needed, as the pathogen fitness may also depend on
the host available resources (44). Future studies should focus
on the transmission potential of malnutritional statuses. In the
past, these conditions were suggested to negatively influence
the transmission of alphaviruses to other hosts (45). Since
most of infected cases are asymptomatic, the spreading of the
virus is much easier than the previous coronaviruses (46). Yet,
the risk of contracting SARS-CoV-2 does not depend on the
individual’s nutritional status but on the degree of contact with
the pathogen. Whether the coronavirus exposure develops into
a true infection might contrariwise depend on the individual’s
first-line abilities, and, regrettably, malnutrition is a common
occurrence that afflicts many older adults in China (47) and Italy
(48), both having been heavily afflicted by the highest number
of deaths. It is clear that the segment of population most at
risk of SARS-CoV-2 infection is the elderly, with frailty (49)
and older age (50) being well-known predictors of a negative
outcome in acute care settings. Intensive clinical monitoring at
admission with subsequent tailored nutritional care is needed
for COVID-19 patients, especially those with co-existing chronic
conditions or medications that could further aggravate the
nutritional status (51). To conclude, there are several main
nutritional issues to consider when fighting COVID-19 (see
Figure 1 for details). A malnutritional status is associated with
immune dysfunction. Malnourished individuals may be more
susceptible to SARS-CoV-2 infection. Subjects with COVID-19
often becomemalnourished. Nutritional support is vital in severe
COVID-19 patients.
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